EYECARE: Coronavirus BRIEFING: Crisis Response Tactics COVID-19 and Rates of Cancer Diagnosis in the U.S. By Staff Thursday, September 12, 2024 6:09 AM A cross-sectional study suggested that cancer cases in the U.S. continued to be underdiagnosed in the second year of the COVID-19 pandemic, according to JAMA Network Open. This population-based cross-sectional study found that rates of observed cancer diagnoses improved in 2021 but still remained a significant 2.7% lower than expected. Among screening-detected cancers, female breast cancer showed significant rate recovery in 2021, colorectal cancer returned to prepandemic trends, and significant reductions in diagnoses remained for lung and cervical cancers.This population-based cross-sectional study of U.S. cancer incidence trends found that rates of diagnosis improved in 2021 but continued to be lower than expected, adding to the existing deficit of diagnosed cases from 2020. Particular attention should be directed at strategies to immediately increase cancer screenings to make up lost ground. Head over to MedPage Today to read more about it.